Any contraindication according to the Austrian SmPC, which includes: A hypersensitivity to any component of Etanercept, active tuberculosis or any other serious infection.

Condition : Rheumatoid Arthritis and Plaque Psoriasis Intervention : Drug: Etanercept Sponsors : Amgen; Amgen Recruiting - verified August 2013

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Not yet recruiting - verified September 2013

Condition : Osteoarthritis Interventions : Drug: Tranexamic Acid (TXA); Drug: ε-Aminocaproic Acid (EACA) Sponsors : Miller Orthopedic Specialists; Alegent Creighton Health Mercy Hospital; Creighton Un...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsor : Hoffmann-La Roche Withdrawn - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate Sponsor : Hoffmann-La Roche Withdrawn - verified November 2013

Condition : Moderate to Severe Rheumatoid Arthritis Intervention : Biological: etanercept Sponsor : Amgen Recruiting - verified February 2014

Condition : Moderate to Severe Rheumatoid Arthritis Intervention : Biological: etanercept Sponsor : Amgen Recruiting - verified November 2013

Condition : Moderate to Severe Rheumatoid Arthritis Intervention : Biological: etanercept Sponsors : Amgen; Amgen Recruiting - verified September 2013

Condition : Spondylitis, Ankylosing Interventions : Drug: Ixekizumab; Drug: Placebo; Drug: Adalimumab Sponsors : Eli Lilly and Company; Eli Lilly and Company Not yet recruiting - verified September 20...